Medical Care

Global Dermatology Biosimilar Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Dermatology Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology Biosimilar.
The Dermatology Biosimilar market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dermatology Biosimilar market comprehensively. Regional market sizes, concerning products by Type, by Application, by Therapeutic Indication and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatology Biosimilar companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sandoz AG
Pfizer
Amgen
Samsung Bioepis
Celltrion
Biocon
Viatris
Alvotech
Segment by Type
Adalimumab Biosimilars
Etanercept Biosimilars
Infliximab Biosimilars
Ustekinumab Biosimilars
Others
Segment by Therapeutic Indication
Psoriasis
Atopic Dermatitis
Alopecia Areata
Other
Segment by Route of Administration
Subcutaneous Injection
Intravenous Injection
Other
Segment by Application
Hospitals
Clinic
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Therapeutic Indication etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatology Biosimilar company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology Biosimilar Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adalimumab Biosimilars
1.2.3 Etanercept Biosimilars
1.2.4 Infliximab Biosimilars
1.2.5 Ustekinumab Biosimilars
1.2.6 Others
1.3 Market by Therapeutic Indication
1.3.1 Global Dermatology Biosimilar Market Size Growth Rate by Therapeutic Indication: 2020 VS 2024 VS 2031
1.3.2 Psoriasis
1.3.3 Atopic Dermatitis
1.3.4 Alopecia Areata
1.3.5 Other
1.4 Market by Route of Administration
1.4.1 Global Dermatology Biosimilar Market Size Growth Rate by Route of Administration: 2020 VS 2024 VS 2031
1.4.2 Subcutaneous Injection
1.4.3 Intravenous Injection
1.4.4 Other
1.5 Market by Application
1.5.1 Global Dermatology Biosimilar Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Dermatology Biosimilar Market Perspective (2020-2031)
2.2 Global Dermatology Biosimilar Growth Trends by Region
2.2.1 Global Dermatology Biosimilar Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Dermatology Biosimilar Historic Market Size by Region (2020-2025)
2.2.3 Dermatology Biosimilar Forecasted Market Size by Region (2026-2031)
2.3 Dermatology Biosimilar Market Dynamics
2.3.1 Dermatology Biosimilar Industry Trends
2.3.2 Dermatology Biosimilar Market Drivers
2.3.3 Dermatology Biosimilar Market Challenges
2.3.4 Dermatology Biosimilar Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatology Biosimilar Players by Revenue
3.1.1 Global Top Dermatology Biosimilar Players by Revenue (2020-2025)
3.1.2 Global Dermatology Biosimilar Revenue Market Share by Players (2020-2025)
3.2 Global Top Dermatology Biosimilar Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Dermatology Biosimilar Revenue
3.4 Global Dermatology Biosimilar Market Concentration Ratio
3.4.1 Global Dermatology Biosimilar Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology Biosimilar Revenue in 2024
3.5 Global Key Players of Dermatology Biosimilar Head office and Area Served
3.6 Global Key Players of Dermatology Biosimilar, Product and Application
3.7 Global Key Players of Dermatology Biosimilar, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatology Biosimilar Breakdown Data by Type
4.1 Global Dermatology Biosimilar Historic Market Size by Type (2020-2025)
4.2 Global Dermatology Biosimilar Forecasted Market Size by Type (2026-2031)
5 Dermatology Biosimilar Breakdown Data by Application
5.1 Global Dermatology Biosimilar Historic Market Size by Application (2020-2025)
5.2 Global Dermatology Biosimilar Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Dermatology Biosimilar Market Size (2020-2031)
6.2 North America Dermatology Biosimilar Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Dermatology Biosimilar Market Size by Country (2020-2025)
6.4 North America Dermatology Biosimilar Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatology Biosimilar Market Size (2020-2031)
7.2 Europe Dermatology Biosimilar Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Dermatology Biosimilar Market Size by Country (2020-2025)
7.4 Europe Dermatology Biosimilar Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Dermatology Biosimilar Market Size (2020-2031)
8.2 Asia-Pacific Dermatology Biosimilar Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Dermatology Biosimilar Market Size by Region (2020-2025)
8.4 Asia-Pacific Dermatology Biosimilar Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Dermatology Biosimilar Market Size (2020-2031)
9.2 Latin America Dermatology Biosimilar Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Dermatology Biosimilar Market Size by Country (2020-2025)
9.4 Latin America Dermatology Biosimilar Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatology Biosimilar Market Size (2020-2031)
10.2 Middle East & Africa Dermatology Biosimilar Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Dermatology Biosimilar Market Size by Country (2020-2025)
10.4 Middle East & Africa Dermatology Biosimilar Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sandoz AG
11.1.1 Sandoz AG Company Details
11.1.2 Sandoz AG Business Overview
11.1.3 Sandoz AG Dermatology Biosimilar Introduction
11.1.4 Sandoz AG Revenue in Dermatology Biosimilar Business (2020-2025)
11.1.5 Sandoz AG Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Dermatology Biosimilar Introduction
11.2.4 Pfizer Revenue in Dermatology Biosimilar Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Dermatology Biosimilar Introduction
11.3.4 Amgen Revenue in Dermatology Biosimilar Business (2020-2025)
11.3.5 Amgen Recent Development
11.4 Samsung Bioepis
11.4.1 Samsung Bioepis Company Details
11.4.2 Samsung Bioepis Business Overview
11.4.3 Samsung Bioepis Dermatology Biosimilar Introduction
11.4.4 Samsung Bioepis Revenue in Dermatology Biosimilar Business (2020-2025)
11.4.5 Samsung Bioepis Recent Development
11.5 Celltrion
11.5.1 Celltrion Company Details
11.5.2 Celltrion Business Overview
11.5.3 Celltrion Dermatology Biosimilar Introduction
11.5.4 Celltrion Revenue in Dermatology Biosimilar Business (2020-2025)
11.5.5 Celltrion Recent Development
11.6 Biocon
11.6.1 Biocon Company Details
11.6.2 Biocon Business Overview
11.6.3 Biocon Dermatology Biosimilar Introduction
11.6.4 Biocon Revenue in Dermatology Biosimilar Business (2020-2025)
11.6.5 Biocon Recent Development
11.7 Viatris
11.7.1 Viatris Company Details
11.7.2 Viatris Business Overview
11.7.3 Viatris Dermatology Biosimilar Introduction
11.7.4 Viatris Revenue in Dermatology Biosimilar Business (2020-2025)
11.7.5 Viatris Recent Development
11.8 Alvotech
11.8.1 Alvotech Company Details
11.8.2 Alvotech Business Overview
11.8.3 Alvotech Dermatology Biosimilar Introduction
11.8.4 Alvotech Revenue in Dermatology Biosimilar Business (2020-2025)
11.8.5 Alvotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Dermatology Biosimilar Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Adalimumab Biosimilars
Table 3. Key Players of Etanercept Biosimilars
Table 4. Key Players of Infliximab Biosimilars
Table 5. Key Players of Ustekinumab Biosimilars
Table 6. Key Players of Others
Table 7. Global Dermatology Biosimilar Market Size Growth Rate by Therapeutic Indication (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of Psoriasis
Table 9. Key Players of Atopic Dermatitis
Table 10. Key Players of Alopecia Areata
Table 11. Key Players of Other
Table 12. Global Dermatology Biosimilar Market Size Growth Rate by Route of Administration (US$ Million): 2020 VS 2024 VS 2031
Table 13. Key Players of Subcutaneous Injection
Table 14. Key Players of Intravenous Injection
Table 15. Key Players of Other
Table 16. Global Dermatology Biosimilar Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Dermatology Biosimilar Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Dermatology Biosimilar Market Size by Region (2020-2025) & (US$ Million)
Table 19. Global Dermatology Biosimilar Market Share by Region (2020-2025)
Table 20. Global Dermatology Biosimilar Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 21. Global Dermatology Biosimilar Market Share by Region (2026-2031)
Table 22. Dermatology Biosimilar Market Trends
Table 23. Dermatology Biosimilar Market Drivers
Table 24. Dermatology Biosimilar Market Challenges
Table 25. Dermatology Biosimilar Market Restraints
Table 26. Global Dermatology Biosimilar Revenue by Players (2020-2025) & (US$ Million)
Table 27. Global Dermatology Biosimilar Market Share by Players (2020-2025)
Table 28. Global Top Dermatology Biosimilar Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology Biosimilar as of 2024)
Table 29. Ranking of Global Top Dermatology Biosimilar Companies by Revenue (US$ Million) in 2024
Table 30. Global 5 Largest Players Market Share by Dermatology Biosimilar Revenue (CR5 and HHI) & (2020-2025)
Table 31. Global Key Players of Dermatology Biosimilar, Headquarters and Area Served
Table 32. Global Key Players of Dermatology Biosimilar, Product and Application
Table 33. Global Key Players of Dermatology Biosimilar, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Dermatology Biosimilar Market Size by Type (2020-2025) & (US$ Million)
Table 36. Global Dermatology Biosimilar Revenue Market Share by Type (2020-2025)
Table 37. Global Dermatology Biosimilar Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 38. Global Dermatology Biosimilar Revenue Market Share by Type (2026-2031)
Table 39. Global Dermatology Biosimilar Market Size by Application (2020-2025) & (US$ Million)
Table 40. Global Dermatology Biosimilar Revenue Market Share by Application (2020-2025)
Table 41. Global Dermatology Biosimilar Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 42. Global Dermatology Biosimilar Revenue Market Share by Application (2026-2031)
Table 43. North America Dermatology Biosimilar Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. North America Dermatology Biosimilar Market Size by Country (2020-2025) & (US$ Million)
Table 45. North America Dermatology Biosimilar Market Size by Country (2026-2031) & (US$ Million)
Table 46. Europe Dermatology Biosimilar Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Europe Dermatology Biosimilar Market Size by Country (2020-2025) & (US$ Million)
Table 48. Europe Dermatology Biosimilar Market Size by Country (2026-2031) & (US$ Million)
Table 49. Asia-Pacific Dermatology Biosimilar Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 50. Asia-Pacific Dermatology Biosimilar Market Size by Region (2020-2025) & (US$ Million)
Table 51. Asia-Pacific Dermatology Biosimilar Market Size by Region (2026-2031) & (US$ Million)
Table 52. Latin America Dermatology Biosimilar Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 53. Latin America Dermatology Biosimilar Market Size by Country (2020-2025) & (US$ Million)
Table 54. Latin America Dermatology Biosimilar Market Size by Country (2026-2031) & (US$ Million)
Table 55. Middle East & Africa Dermatology Biosimilar Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 56. Middle East & Africa Dermatology Biosimilar Market Size by Country (2020-2025) & (US$ Million)
Table 57. Middle East & Africa Dermatology Biosimilar Market Size by Country (2026-2031) & (US$ Million)
Table 58. Sandoz AG Company Details
Table 59. Sandoz AG Business Overview
Table 60. Sandoz AG Dermatology Biosimilar Product
Table 61. Sandoz AG Revenue in Dermatology Biosimilar Business (2020-2025) & (US$ Million)
Table 62. Sandoz AG Recent Development
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Dermatology Biosimilar Product
Table 66. Pfizer Revenue in Dermatology Biosimilar Business (2020-2025) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Dermatology Biosimilar Product
Table 71. Amgen Revenue in Dermatology Biosimilar Business (2020-2025) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Samsung Bioepis Company Details
Table 74. Samsung Bioepis Business Overview
Table 75. Samsung Bioepis Dermatology Biosimilar Product
Table 76. Samsung Bioepis Revenue in Dermatology Biosimilar Business (2020-2025) & (US$ Million)
Table 77. Samsung Bioepis Recent Development
Table 78. Celltrion Company Details
Table 79. Celltrion Business Overview
Table 80. Celltrion Dermatology Biosimilar Product
Table 81. Celltrion Revenue in Dermatology Biosimilar Business (2020-2025) & (US$ Million)
Table 82. Celltrion Recent Development
Table 83. Biocon Company Details
Table 84. Biocon Business Overview
Table 85. Biocon Dermatology Biosimilar Product
Table 86. Biocon Revenue in Dermatology Biosimilar Business (2020-2025) & (US$ Million)
Table 87. Biocon Recent Development
Table 88. Viatris Company Details
Table 89. Viatris Business Overview
Table 90. Viatris Dermatology Biosimilar Product
Table 91. Viatris Revenue in Dermatology Biosimilar Business (2020-2025) & (US$ Million)
Table 92. Viatris Recent Development
Table 93. Alvotech Company Details
Table 94. Alvotech Business Overview
Table 95. Alvotech Dermatology Biosimilar Product
Table 96. Alvotech Revenue in Dermatology Biosimilar Business (2020-2025) & (US$ Million)
Table 97. Alvotech Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report


List of Figures
Figure 1. Dermatology Biosimilar Picture
Figure 2. Global Dermatology Biosimilar Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dermatology Biosimilar Market Share by Type: 2024 VS 2031
Figure 4. Adalimumab Biosimilars Features
Figure 5. Etanercept Biosimilars Features
Figure 6. Infliximab Biosimilars Features
Figure 7. Ustekinumab Biosimilars Features
Figure 8. Others Features
Figure 9. Global Dermatology Biosimilar Market Size Comparison by Therapeutic Indication (2020-2031) & (US$ Million)
Figure 10. Psoriasis Features
Figure 11. Atopic Dermatitis Features
Figure 12. Alopecia Areata Features
Figure 13. Other Features
Figure 14. Global Dermatology Biosimilar Market Size Comparison by Route of Administration (2020-2031) & (US$ Million)
Figure 15. Subcutaneous Injection Features
Figure 16. Intravenous Injection Features
Figure 17. Other Features
Figure 18. Global Dermatology Biosimilar Market Size by Application (2020-2031) & (US$ Million)
Figure 19. Global Dermatology Biosimilar Market Share by Application: 2024 VS 2031
Figure 20. Hospitals Case Studies
Figure 21. Clinic Case Studies
Figure 22. Other Case Studies
Figure 23. Dermatology Biosimilar Report Years Considered
Figure 24. Global Dermatology Biosimilar Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 25. Global Dermatology Biosimilar Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 26. Global Dermatology Biosimilar Market Share by Region: 2024 VS 2031
Figure 27. Global Dermatology Biosimilar Market Share by Players in 2024
Figure 28. Global Dermatology Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 29. The Top 10 and 5 Players Market Share by Dermatology Biosimilar Revenue in 2024
Figure 30. North America Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. North America Dermatology Biosimilar Market Share by Country (2020-2031)
Figure 32. United States Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Canada Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Europe Dermatology Biosimilar Market Share by Country (2020-2031)
Figure 36. Germany Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. France Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. U.K. Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Italy Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Russia Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Ireland Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Dermatology Biosimilar Market Share by Region (2020-2031)
Figure 44. China Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Japan Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. South Korea Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. India Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Australia & New Zealand Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Latin America Dermatology Biosimilar Market Share by Country (2020-2031)
Figure 52. Mexico Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Brazil Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Middle East & Africa Dermatology Biosimilar Market Share by Country (2020-2031)
Figure 56. Israel Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. UAE Dermatology Biosimilar Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. Sandoz AG Revenue Growth Rate in Dermatology Biosimilar Business (2020-2025)
Figure 60. Pfizer Revenue Growth Rate in Dermatology Biosimilar Business (2020-2025)
Figure 61. Amgen Revenue Growth Rate in Dermatology Biosimilar Business (2020-2025)
Figure 62. Samsung Bioepis Revenue Growth Rate in Dermatology Biosimilar Business (2020-2025)
Figure 63. Celltrion Revenue Growth Rate in Dermatology Biosimilar Business (2020-2025)
Figure 64. Biocon Revenue Growth Rate in Dermatology Biosimilar Business (2020-2025)
Figure 65. Viatris Revenue Growth Rate in Dermatology Biosimilar Business (2020-2025)
Figure 66. Alvotech Revenue Growth Rate in Dermatology Biosimilar Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies